Picato (ingenol mebutate) - Important Safety Information from LEO Pharma as approved by the HPRA

Notice type: 3rd Party Publications

Date: 30/01/2020




Problem Or Issue:

Important Safety Information from LEO Pharma regarding Picato (ingenol mebutate) – Suspension of the marketing authorisation due to risk of skin malignancy

 

Important Safety Information - Picato (ingenol mebutate)




« Back